Publications by authors named "Karoline Kollmann"

18Publications

The role of CDK6 in cancer.

Int J Cancer 2020 Dec 30;147(11):2988-2995. Epub 2020 May 30.

Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.33054DOI Listing
December 2020

CDK6 Inhibition: A Novel Approach in AML Management.

Int J Mol Sci 2020 Apr 5;21(7). Epub 2020 Apr 5.

Institute of Pharmacology and Toxicology, University of Veterinary Medicine, 1210 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms21072528DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178035PMC
April 2020

The interplay of CDK4 and CDK6 in melanoma.

Oncotarget 2019 Feb 15;10(14):1346-1359. Epub 2019 Feb 15.

Department of Dermatology, Division of General Dermatology, Medical University Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/26515
Publisher Site
http://dx.doi.org/10.18632/oncotarget.26515DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402717PMC
February 2019

CDK6 and p16INK4A in lymphoid malignancies.

Oncotarget 2013 Nov;4(11):1858-9

Cambridge Institute for Medical Research and Welcome Trust/MRC Stem Cell Institute and Department of Hematology; University of Cambridge; Cambridge, UK.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/1541
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875750PMC
http://dx.doi.org/10.18632/oncotarget.1541DOI Listing
November 2013

Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma.

Biochimie 2012 Nov 9;94(11):2297-307. Epub 2012 Jun 9.

Clinical Institute of Pathology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biochi.2012.05.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480637PMC
November 2012

c-JUN prevents methylation of p16(INK4a) (and Cdk6): the villain turned bodyguard.

Oncotarget 2011 May;2(5):422-7

Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria. Karoline.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248190PMC
http://dx.doi.org/10.18632/oncotarget.279DOI Listing
May 2011